Prisho Mariam Paul

Prisho Mariam Paul

Assistant Professor 
Email: [email protected]

Education

  • BSc., Kerala University, 2007
  • MSc., Bharathiar University, 2009
  • M.Phil., Kerala University, 2011
  • Ph.D (Ongoing)

Research focuses on employing cutting-edge in-silico techniques to investigate the mutagenic capability and pathogenicity of SARS-CoV2, the virus responsible for COVID-19. By utilizing advanced computational tools, we aim to unravel the molecular intricacies of viral-host interactions, identify key mutational hotspots, and assess the structural basis of pathogenicity.

MSc. Biotechnology

  • BTPG03 Biophysics and Bioinformatics
  • BTPG04 Instrumentation and Biostatistics

BSc. Biotechnology

  • BO&BT1A01U Operating Systems and Office Automation (IT)
  • BP&BT2BBT02U Biostatistics
  • BO&BT4BBT07U Bioinformatics

Click Here

  • Paper” In Silico Screening of Phytochemicals of Tylophora indica(Burm.f.)Merill Against E protein of Omicron variant”, International Conference on Translational Research in Drug Discovery and Development for Sustainable Healthcare by Centre
    for Drug Discovery and Development, Sathybama University, Chennai, 3-5 May 2023.
  • Presented a oral paper entitled “In silico mutational Profiling on S protein in Indian Delta SARS-CoV-2”in the International Virtual conference on SARS CoV-2 contagion:Lessons learnt on the 15 th and 16 th December 2021 conducted by the department of Microbiology, Sree Balaji Dental College and Hospital BIHER Chennai.

  • Secured 2nd Position for paper entitled “Insilico docking analysis of FDA approved drugs against Human AKR1 protein binding site of SARSCoV-2 membrane protein” in the National Conference RICERCA 2022, organized by IQAC & Research
    Committee, St. Joseph’s College for Women, Alappuzha in association with KSSP,IIC,CSIR-IMMT & KSCSTE during 27/09/2022 to 1/10/2022.
  • Secured First place in Oral presentation entitled “In silico docking analysis of the FDA approved drugs on envelope protein of SARS CoV-2 Omicron variant” in the International Conference on Pharmaceutics & Novel Drug Discovery- [Virtual]organized by Sathyabama Institute of Science and Technology, India and MAHSA University, Malaysia held on 21-23 April 2022.
  • Secured First placed in Oral presentation entitled “An immuno-informatics study to predict the mutational effect of B cell epitopes in E and M proteins of SARSCoV-2 Indian delta variants” in the international e Conference on Bioengineering for Health Environment (ICBHE2021) organized by Sathyabama Institute of Science and Technology, India and MAHSA University, Malaysia held on 16th and 17th December2021.
  • Secured 2nd Position for paper entitled “In silico mutational Stability Profiling and functional analysis of Spike protein in Indian SARS-CoV-2 delta variants” in the National Conference RICERCA 2021, organized by IQAC Research Committee, St. Joseph’s College for Women, Alappuzha in association with Kerala Sasthra Sahithya Parishath & Society of Biotechnologists, India during 5th – 11th October 2021.

Biotechnology
Department